Background: A risk-adapted approach to management of thyroid cancer requires risk
estimates that change over time based on response to therapy and the course of the …

Background: Increased incidence of small differentiated thyroid cancer (DTC) has
emphasized the need for risk stratification and individualized disease management for these …

Objective To describe the risk of structural disease recurrence in a cohort of patients with
differentiated thyroid cancer selected for treatment with either thyroid lobectomy or total …

Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total …

Background: The American Thyroid Association (ATA), the European Association of Nuclear
Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and …

Background: The American Thyroid Association guidelines recommend the routine use of
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …

Management recommendations for differentiated thyroid cancer are evolving. Total
thyroidectomy is the backbone of curative-intent therapy, with radioiodine ablation (RAI) of …

Objectives: The aims of this study were to validate the proposed Latin American Thyroid
Society (LATS) risk of recurrence stratification system and to compare the findings with those …

Background: One of the most widely used risk stratification systems for estimating individual
patients' risk of persistent or recurrent differentiated thyroid cancer (DTC) is the American …

Context: American Thyroid Association and European Thyroid Association guidelines
cannot recommend for or against radioactive iodine (RAI) ablation after surgery in low-risk …